MCL coexpression mm9:1034
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Short description | |
---|---|
Mm9::chr10:62523378..62523405,+ | p2@Pbld1 |
Mm9::chr12:33987111..33987131,+ | p10@Atxn7l1 |
Mm9::chr12:74968671..74968675,+ | p@chr12:74968671..74968675 + |
Mm9::chr17:43804437..43804461,+ | p2@Cyp39a1 |
Mm9::chr6:139535719..139535751,+ | p1@Pik3c2g |
Mm9::chr6:139845232..139845235,+ | p@chr6:139845232..139845235 + |
Mm9::chr8:108659441..108659470,+ | p2@ENSMUST00000140509 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0033782 | 24-hydroxycholesterol 7alpha-hydroxylase activity | 0.00442654832323127 |
GO:0008387 | steroid 7-alpha-hydroxylase activity | 0.00442654832323127 |
GO:0030573 | bile acid catabolic process | 0.00442654832323127 |
GO:0008396 | oxysterol 7-alpha-hydroxylase activity | 0.00442654832323127 |
GO:0035005 | phosphatidylinositol-4-phosphate 3-kinase activity | 0.00442654832323127 |
GO:0006707 | cholesterol catabolic process | 0.00553197275074394 |
GO:0016127 | sterol catabolic process | 0.00553197275074394 |
GO:0006699 | bile acid biosynthetic process | 0.00553197275074394 |
GO:0046395 | carboxylic acid catabolic process | 0.00553197275074394 |
GO:0006706 | steroid catabolic process | 0.00553197275074394 |
GO:0016054 | organic acid catabolic process | 0.00553197275074394 |
GO:0044255 | cellular lipid metabolic process | 0.00553197275074394 |
GO:0046854 | phosphoinositide phosphorylation | 0.00553197275074394 |
GO:0035004 | phosphoinositide 3-kinase activity | 0.00553197275074394 |
GO:0016303 | 1-phosphatidylinositol-3-kinase activity | 0.00553197275074394 |
GO:0006629 | lipid metabolic process | 0.00553197275074394 |
GO:0005942 | phosphoinositide 3-kinase complex | 0.00553197275074394 |
GO:0016307 | phosphatidylinositol phosphate kinase activity | 0.00553197275074394 |
GO:0046834 | lipid phosphorylation | 0.00553197275074394 |
GO:0008395 | steroid hydroxylase activity | 0.00553197275074394 |
GO:0008206 | bile acid metabolic process | 0.00579524122475263 |
GO:0001727 | lipid kinase activity | 0.0105578556728842 |
GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen | 0.0105794246050111 |
GO:0030258 | lipid modification | 0.0105991708625171 |
GO:0044242 | cellular lipid catabolic process | 0.0119091415279413 |
GO:0004428 | inositol or phosphatidylinositol kinase activity | 0.0119091415279413 |
GO:0007586 | digestion | 0.0163775564470731 |
GO:0048015 | phosphoinositide-mediated signaling | 0.0167710368873478 |
GO:0030384 | phosphoinositide metabolic process | 0.0167710368873478 |
GO:0006650 | glycerophospholipid metabolic process | 0.0213621610797628 |
GO:0008203 | cholesterol metabolic process | 0.0228078961176848 |
GO:0006694 | steroid biosynthetic process | 0.0230363935280724 |
GO:0016125 | sterol metabolic process | 0.0230363935280724 |
GO:0016053 | organic acid biosynthetic process | 0.0230363935280724 |
GO:0046394 | carboxylic acid biosynthetic process | 0.0230363935280724 |
GO:0016042 | lipid catabolic process | 0.0280437053928451 |
GO:0044445 | cytosolic part | 0.0280437053928451 |
GO:0020037 | heme binding | 0.0314025432472364 |
GO:0046906 | tetrapyrrole binding | 0.0314025432472364 |
GO:0006644 | phospholipid metabolic process | 0.0319922495485837 |
GO:0019932 | second-messenger-mediated signaling | 0.0320612840675953 |
GO:0004497 | monooxygenase activity | 0.0320612840675953 |
GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 0.0320612840675953 |
GO:0008202 | steroid metabolic process | 0.0350780635844419 |
GO:0006643 | membrane lipid metabolic process | 0.0366554511166649 |
GO:0005792 | microsome | 0.0366554511166649 |
GO:0042598 | vesicular fraction | 0.0368094199443403 |
GO:0035091 | phosphoinositide binding | 0.0376422993612194 |
GO:0005543 | phospholipid binding | 0.0449238549794652 |
GO:0032787 | monocarboxylic acid metabolic process | 0.0468702382571968 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
trunk region element | 6.06e-21 | 79 |
trunk | 1.40e-17 | 90 |
immaterial anatomical entity | 6.31e-17 | 79 |
liver | 1.77e-14 | 22 |
epithelial sac | 1.77e-14 | 22 |
digestive gland | 1.77e-14 | 22 |
epithelium of foregut-midgut junction | 1.77e-14 | 22 |
anatomical boundary | 1.77e-14 | 22 |
hepatobiliary system | 1.77e-14 | 22 |
foregut-midgut junction | 1.77e-14 | 22 |
hepatic diverticulum | 1.77e-14 | 22 |
liver primordium | 1.77e-14 | 22 |
septum transversum | 1.77e-14 | 22 |
liver bud | 1.77e-14 | 22 |
digestive tract diverticulum | 1.76e-13 | 23 |
sac | 1.76e-13 | 23 |
exocrine gland | 2.04e-13 | 25 |
exocrine system | 2.04e-13 | 25 |
subdivision of trunk | 1.27e-12 | 66 |
abdomen element | 1.99e-10 | 49 |
abdominal segment element | 1.99e-10 | 49 |
abdominal segment of trunk | 1.99e-10 | 49 |
abdomen | 1.99e-10 | 49 |
pancreas | 8.68e-10 | 12 |
trunk mesenchyme | 5.85e-09 | 45 |
foregut | 1.27e-07 | 80 |
mesenchyme | 2.73e-07 | 61 |
entire embryonic mesenchyme | 2.73e-07 | 61 |
viscus | 4.22e-07 | 19 |
subdivision of digestive tract | 8.38e-07 | 114 |
digestive system | 8.99e-07 | 116 |
digestive tract | 8.99e-07 | 116 |
primitive gut | 8.99e-07 | 116 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.0286946 |
MA0004.1 | 0.481116 |
MA0006.1 | 0.311391 |
MA0007.1 | 0.465969 |
MA0009.1 | 0.92425 |
MA0014.1 | 0.0200028 |
MA0017.1 | 0.337808 |
MA0019.1 | 0.740036 |
MA0024.1 | 0.880057 |
MA0025.1 | 1.15921 |
MA0027.1 | 2.57545 |
MA0028.1 | 0.321735 |
MA0029.1 | 1.99617 |
MA0030.1 | 0.864739 |
MA0031.1 | 1.93597 |
MA0038.1 | 0.62758 |
MA0040.1 | 0.936879 |
MA0041.1 | 1.04397 |
MA0042.1 | 1.79544 |
MA0043.1 | 1.02178 |
MA0046.1 | 2.20556 |
MA0048.1 | 0.40238 |
MA0050.1 | 0.520357 |
MA0051.1 | 0.636645 |
MA0052.1 | 0.945011 |
MA0055.1 | 0.0406078 |
MA0056.1 | 0 |
MA0057.1 | 0.117936 |
MA0058.1 | 0.384683 |
MA0059.1 | 0.397033 |
MA0060.1 | 0.656954 |
MA0061.1 | 0.724575 |
MA0063.1 | 0 |
MA0066.1 | 0.616444 |
MA0067.1 | 1.27078 |
MA0068.1 | 0.385183 |
MA0069.1 | 0.945354 |
MA0070.1 | 0.93557 |
MA0071.1 | 0.519509 |
MA0072.1 | 0.927016 |
MA0073.1 | 0.00223012 |
MA0074.1 | 0.580087 |
MA0076.1 | 0.356883 |
MA0077.1 | 0.905143 |
MA0078.1 | 1.60783 |
MA0081.1 | 0.420276 |
MA0083.1 | 1.02098 |
MA0084.1 | 1.59945 |
MA0087.1 | 0.977537 |
MA0088.1 | 0.0841779 |
MA0089.1 | 0 |
MA0090.1 | 1.1347 |
MA0091.1 | 0.494398 |
MA0092.1 | 0.446857 |
MA0093.1 | 0.879104 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.568369 |
MA0101.1 | 0.406019 |
MA0103.1 | 0.920496 |
MA0105.1 | 0.162418 |
MA0106.1 | 0.677988 |
MA0107.1 | 0.342432 |
MA0108.2 | 0.763162 |
MA0109.1 | 0 |
MA0111.1 | 0.460823 |
MA0113.1 | 0.649407 |
MA0114.1 | 0.719313 |
MA0115.1 | 1.0246 |
MA0116.1 | 0.836994 |
MA0117.1 | 0.992087 |
MA0119.1 | 1.04809 |
MA0122.1 | 1.01209 |
MA0124.1 | 1.21735 |
MA0125.1 | 1.14291 |
MA0130.1 | 0 |
MA0131.1 | 0.735438 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 1.05845 |
MA0136.1 | 0.600242 |
MA0139.1 | 0.202522 |
MA0140.1 | 0.568252 |
MA0141.1 | 0.964041 |
MA0142.1 | 0.814115 |
MA0143.1 | 0.665982 |
MA0144.1 | 0.72625 |
MA0145.1 | 1.05551 |
MA0146.1 | 0.108739 |
MA0147.1 | 0.274511 |
MA0148.1 | 1.24416 |
MA0149.1 | 0.411562 |
MA0062.2 | 0.167299 |
MA0035.2 | 1.40435 |
MA0039.2 | 0.113749 |
MA0138.2 | 0.727395 |
MA0002.2 | 0.205289 |
MA0137.2 | 0.957645 |
MA0104.2 | 0.624968 |
MA0047.2 | 0.626803 |
MA0112.2 | 0.0910939 |
MA0065.2 | 0.633155 |
MA0150.1 | 0.465855 |
MA0151.1 | 0 |
MA0152.1 | 0.626912 |
MA0153.1 | 1.07519 |
MA0154.1 | 0.126143 |
MA0155.1 | 0.687925 |
MA0156.1 | 0.356017 |
MA0157.1 | 1.83902 |
MA0158.1 | 0 |
MA0159.1 | 0.284457 |
MA0160.1 | 0.50056 |
MA0161.1 | 0 |
MA0162.1 | 0.0312493 |
MA0163.1 | 0.0280055 |
MA0164.1 | 1.46244 |
MA0080.2 | 0.343316 |
MA0018.2 | 0.610433 |
MA0099.2 | 0.721008 |
MA0079.2 | 0.105858 |
MA0102.2 | 1.65195 |
MA0258.1 | 0.246285 |
MA0259.1 | 0.26402 |
MA0442.1 | 0 |